4//SEC Filing
Seres Therapeutics, Inc. 4
Accession 0000899243-16-012642
$MCRBCIK 0001609809operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:00 PM ET
Size
5.6 KB
Accession
0000899243-16-012642
Insider Transaction Report
Form 4
Trucksis Michele
Chief Medical Officer and EVP
Transactions
- Award
Stock Option (Right to Buy)
2016-02-01+62,500→ 62,500 totalExercise: $26.20Exp: 2026-01-31→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares subject to the option on February 1, 2017, and as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:00 PM ET
- Size
- 5.6 KB